Regeneron deepens relationship with CytomX, adding up to $2B and eight targets

BioSpace

All told, CytomX Therapeutics now stands to receive up to $4 billion over the course of its partnership with Regeneron, if all milestones are met.

pharminent June 4, 2026 (Last updated: June 4, 2026)

BioSpace

All told, CytomX Therapeutics now stands to receive up to $4 billion over the course of its partnership with Regeneron, if all milestones are met.

Related Stories